Thomson Health head steps down

Share this article:
Kevin King, president and CEO of Thomson Healthcare, has left the company. It remains unclear whether he will be replaced, company officials said.

King left the firm towards the end of June. He arrived in March of 2005 from GE Medical Systems Information Technologies and GE Global Clinical Systems. His responsibilities are being absorbed by Bob Cullen, president and CEO of Thomson Scientific and Healthcare.

Thomson announced last month that it would divest its medical education business, which pulled in $97 million in revenue for 2005, accounting for about one tenth of the scientific and healthcare group's total revenues.

Share this article:
close

Next Article in News

Email Newsletters

More in News

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...

Bayer drug gets orphan label

Bayer drug gets orphan label

The FDA designation is for an experimental, inhaled form of ciprofloxacin intended to treat a rare lung condition.

Lilly's cancer drug ramu granted gastric indication

Lilly's cancer drug ramu granted gastric indication

Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.